These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20455854)

  • 41. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological inhibition of TGFβ as a strategy to augment the antitumor immune response.
    Hanks BA; Morse MA
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1342-53. PubMed ID: 21154116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is TGFβ as an anti-inflammatory cytokine required for differentiation of inflammatory T
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    J Immunotoxicol; 2016 Nov; 13(6):775-783. PubMed ID: 27754729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H; Yamane K; Kubo M; Tamaki K
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGFβ pathway inhibition in the treatment of non-small cell lung cancer.
    Eser PÖ; Jänne PA
    Pharmacol Ther; 2018 Apr; 184():112-130. PubMed ID: 29129643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TGFbeta-regulated transcriptional mechanisms in cancer.
    Ellenrieder V; Buck A; Gress TM
    Int J Gastrointest Cancer; 2002; 31(1-3):61-9. PubMed ID: 12622416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TGFβ signaling activation correlates with immune-inflamed tumor microenvironment across human cancers and predicts response to immunotherapy.
    Xia J; Zhang Q; Luan J; Min P; Zhang H; Chen G; Ji C; Song N
    Cell Cycle; 2023 Jan; 22(1):57-72. PubMed ID: 35923142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TGFbeta1, back to the future: revisiting its role as a transforming growth factor.
    Glick AB
    Cancer Biol Ther; 2004 Mar; 3(3):276-83. PubMed ID: 15034302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.
    Du S; Barcellos-Hoff MH
    Semin Radiat Oncol; 2013 Oct; 23(4):242-51. PubMed ID: 24012338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity.
    Tanaka H; Shinto O; Yashiro M; Yamazoe S; Iwauchi T; Muguruma K; Kubo N; Ohira M; Hirakawa K
    Oncol Rep; 2010 Dec; 24(6):1637-43. PubMed ID: 21042762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy.
    Pei S; Huang M; Huang J; Zhu X; Wang H; Romano S; Deng X; Wang Y; Luo Y; Hao S; Xu J; Yu T; Zhu Q; Yuan J; Shen K; Liu Z; Hu G; Peng C; Luo Q; Wen Z; Dai D; Xiao Y
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33914044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling.
    Verona EV; Elkahloun AG; Yang J; Bandyopadhyay A; Yeh IT; Sun LZ
    Cancer Res; 2007 Jun; 67(12):5737-46. PubMed ID: 17575140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
    Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.
    Oshima H; Nakayama M; Han TS; Naoi K; Ju X; Maeda Y; Robine S; Tsuchiya K; Sato T; Sato H; Taketo MM; Oshima M
    Cancer Res; 2015 Feb; 75(4):766-76. PubMed ID: 25687406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor β as regulator of cancer stemness and metastasis.
    Bellomo C; Caja L; Moustakas A
    Br J Cancer; 2016 Sep; 115(7):761-9. PubMed ID: 27537386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGFbeta in Cancer.
    Massagué J
    Cell; 2008 Jul; 134(2):215-30. PubMed ID: 18662538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploiting Canonical TGFβ Signaling in Cancer Treatment.
    Liu Q; Chen G; Moore J; Guix I; Placantonakis D; Barcellos-Hoff MH
    Mol Cancer Ther; 2022 Jan; 21(1):16-24. PubMed ID: 34670783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.